Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Physician Assistant Education : the Official Journal of the Physician Assistant Education Association|February 20, 2024
An Analysis of Mental Health Representation in the Technical Standards of Physician Assistant ProgramsBridget Calhoun, Matthew Swift, Jordan Baney
Arrhythmia & Electrophysiology Review|July 31, 2024
British Heart Rhythm Society Standards for Implantation and Follow-up of Cardiac Rhythm Management Devices in Adults: January 2024 UpdatePaul Foley, Honey Thomas, Mark Dayer, et al.
Journal of Cell Science|June 23, 2018
Sensory neuronal sensitisation occurs through HMGB-1-RAGE and TRPV1 in high-glucose conditionsSamuel M Bestall, Richard P Hulse, Zoe Blackley, et al.
Molecular Cancer Therapeutics|September 12, 2015
Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria BoxHaydar Çelik, Sung-Hyeok Hong, Daisy D Colón-López, et al.
Oncotarget|November 4, 2021
Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survivalSara Maimouni, Mi-Hye Lee, You-Me Sung, et al.
Oncotarget|March 23, 2019
Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survivalSara Maimouni, Mi-Hye Lee, You-Me Sung, et al.
Cancer Research Communications|February 6, 2026
ROME, an ancient gene with a novel function in vertebrates, is a key modulator of embryonal development and cancer metastasisAnna Molotkova, Emre Deniz, Matthew Swift, et al.
Journal of Cardiovascular Electrophysiology|July 17, 2019
His bundle pacing, learning curve, procedure characteristics, safety, and feasibility: Insights from a large international observational studyDaniel Keene, Ahran D Arnold, Marek Jastrzębski, et al.
Heart (British Cardiac Society)|September 19, 2024
Optimising remote monitoring for cardiac implantable electronic devices: a UK Delphi consensusShumaila Ahmad, Sam Straw, John Gierula, et al.
Nature Medicine|July 3, 2019
ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitorDong Li, Michael E March, Alvaro Gutierrez-Uzquiza, et al.
Pageof 1